Research Project
Project Title: |
A Phase 3, Randomized, Double-blinded, Placebo-controlled, multicenter study to evaluate the efficacy and safety of Pegcetacoplan in patients with primary C3 glomerulopathy or Immuno-Complex Membranoproliferative Glomerulonephritis |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
A Phase 3, Randomized, Double-blinded, Placebo-controlled, multicenter study to evaluate the efficacy and safety of Pegcetacoplan in patients with primary C3 glomerulopathy or Immuno-Complex Membranoproliferative Glomerulonephritis |
Lead principal investigator(s): |
Gaetano La Manna, Bologna |
Co-investigator(s): |
Olga Baraldi, Bologna Agnieszka Przygocka, Bologna Serena Speciale, Bologna Gema Ariceta, Barcelona |
Project Period: |
07/2022 - 12/2026 |
Sponsors: |
Industry |
« Back to research page